Background: Hepatocellular carcinoma(HCC)is a third common cause of cancer-related death with highest prevalence in developing countries,which mostly caused by infection with the hepatitis B virus in
Background: A major challenge of chemotherapy in hepatocellular carcinoma(HCC)is to overcome intrinsic or acquired multi-drug resistance(MDR)caused by active drug efflux mediated by ATP-binding casset